Enter Your Email Address to Receive a
Copy of MedicExhange Member Demograhpics

Positron Corporation announced that they will market its complete turnkey offering of radiopharmaceuticals, camera service and imaging for a total solution to customers under the name PosiRx.  Positron’s PosiRx will offer financing and partnership flexibility by providing imaging providers the choice of radiopharmaceuticals, radiopharmaceutical dispensing systems, molecular imaging devices, and equipment service directly from Positron.  Customers can choose all services as a complete package or individual parts that suit their needs.  Positron is able to offer innovative distribution and dose dispensing of radiopharmaceuticals directly to imaging providers as a result of their cutting edge “virtual pharmacy” device named the Nuclear Pharm-Assist.

Positron’s President, Joseph Oliverio stated, “We are addressing the needs of physicians in these challenging economic times by providing them with patient and business flexibility combined with cost effective imaging provision alternatives.” Oliverio also went on to state, “that our new PosiRx™ solution will set a new industry standard for the distribution of radiopharmaceuticals giving Positron a significant market share in the massive radiopharmaceutical and imaging device market.”

About Positron Corporation
Positron Corporation is a vertically integrated company in the field of Cardiac Nuclear Medicine. The Company operates through two segments: Molecular Imaging Devices and Radiopharmaceutical Products. The Molecular Imaging Devices segment provides Positron Emission Tomography (PET) scanners and Single Photon Emission Computed Tomography (SPECT) cameras; the Radiopharmaceutical Products segment offers world’s first robotic systems for distribution and delivery of radiopharmaceuticals and provides radiopharmaceutical agents used for the diagnosis of cardiac diseases. The Company is able to offer a total customer solution which includes molecular imaging devices, disease specific software, radiopharmaceutical distribution and delivery systems, and radiopharmaceuticals agents for Cardiac Nuclear Medicine. Positron Corporation was incorporated in 1983 and is currently headquartered in Houston, Texas. Positron’s SPECT and PET cardiac molecular imaging systems and radiopharmaceutical deliver devices are installed in more than 150 hospitals and physician offices around the world.